Abstract:Purpose/Objective(s) Recent research has categorized the genetic make-up of head and neck squamous cell cancers (HNSCC) at initial presentation. However, despite advances in treatment, up to 50% of patients develop a recurrent/metastatic (R/M) disease, with a significant decline in survival at that time. Here, we aim to analyze the genetic composition of patients with R/M HNSCC to establish the most frequent alterations in this population and determine if there are associations with survival. Materials/Methods We performed an IRB-approved retrospective analysis of patients with confirmed recurrences of head and neck cancer after treatment for curative intent. We collected clinical data from one institution's electronic health records. Patients were grouped into cancer locations [oropharynx, oral cavity, hypopharynx, larynx, nasopharynx]. Targeted DNA sequencing of the tumor samples was performed by Tempus. R square analysis was done to compare tumor genetic make-up. Results To date, a total of 44 patients with head and neck cancer recurrences were included in the analysis. 43.5% of patients had oral cavity cancer, and 32.6% of patients had oropharynx cancer. Seventeen patients (39%) were p16 positive. The median age at the time of diagnosis was 62.5 years (range 36-82), and the majority of patients were male (n=28, 64%). Twenty-four patients (54%) had a current or former smoking history. The median overall survival time was 721 days from the date of diagnosis. The median disease-free survival was 198 days. Survival rate of the entire cohort was 27.2% at the time of analysis. The most common mutation seen in the cohort was TP53, which was present in 29 patients (65%) and was associated with worse overall and disease-free survival. TERT and CDKN2A mutations were seen in 16 patients (36%), but were not associated with outcomes in this small sample size. Notably, both TERT and CDKN2A mutations are less common for the primary HNSCC diagnosis. Additional alterations were noted in PIK3CA (found in 20% of patients) and LRP1B (found in 9% of patients); while the former is associated with better overall survival, the latter was strongly associated with worse disease-free survival. Conclusion In the analysis of the R/M HNSCC cases, we identified genomic alterations similar to those found during primary diagnosis. While HNSCC cancers are genetically heterogeneous, alterations in TP53 remain the most commonly noted. R/M HNSCC populations commonly have CDKN2A and TERT mutations that are rarely found in primary diagnosis. In addition, mutations in LRP1B were associated with worse disease-free survival. Further analysis is ongoing to define the correlation between the mutational landscape of our patients and their response to therapy.

Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma

Identification of neutral tumor evolution across cancer types

The non-coding landscape of head and neck squamous cell carcinoma

Development and Validation of Radiomic Signatures of Head and Neck Squamous Cell Carcinoma Molecular Features and Subtypes.

Karyotypic Evolution and Tumor Progression in Head and Neck Squamous Cell Carcinomas.

Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract

Tumor Genomics and the Association with Survival in Recurrent/metastatic Head and Neck Cancer Patients

Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness

Evolution under Spatially Heterogeneous Selection in Solid Tumors

Expression Profile Analysis of Head and Neck Squamous Cell Carcinomas Using Data from the Cancer Genome Atlas

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases

The Genomic Profiling in Chinese Head and Neck Cancer and Incidence of NTRK Fusion

Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer

Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma

Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer

A Comprehensive Analysis of Exosome‐Related Long Noncoding RNAs as Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma

Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq

Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response

Single-cell integrated transcriptomics reveals the role of keratinocytes in head and neck squamous cell carcinoma

Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma